awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38261371-15E5018B-9809-4C84-86FE-3F015EF95BBE
Q38261371-15E5018B-9809-4C84-86FE-3F015EF95BBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38261371-15E5018B-9809-4C84-86FE-3F015EF95BBE
Selective JAK inhibitors.
P2860
Q38261371-15E5018B-9809-4C84-86FE-3F015EF95BBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38261371-15E5018B-9809-4C84-86FE-3F015EF95BBE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
42b479344aa27b1478bcd154323dc72d33c05930
P2860
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.